Who uses Element AVITI?

AVITI is a benchtop short-read sequencer built on its own chemistry, avidity sequencing. It's made by Element Biosciences. 447 bioRxiv and medRxiv preprints since April 2025 say they used AVITI, 171 in the last 6 months. Updated daily (as of Nov 16)

Is AVITI use still growing?

Yes: 171 preprints used AVITI in Jun–Nov 2026, +50% vs the previous year as a share of all preprints. This is faster than short-read sequencers overall (+8%).

How does AVITI compare with other short-read sequencers?

AVITI is fourth, with 6% of their uses in Jun–Nov 2026, up from 4% the year before. NovaSeq X leads with 44%.

Preprints in the last 6 months

Growth, Jun–Nov 2026 vs Jun–Nov 2025

Which institutions use AVITI most?

The institutions using AVITI most are University of Lausanne, Columbia University and École Polytechnique Fédérale de Lausanne.

Institutions

  1. University of Lausanne18
  2. Columbia University16
  3. École Polytechnique Fédérale de Lausanne12
  4. University of California, Davis12
  5. University of Minnesota10

Where the labs are

  • US60%
  • Switzerland10%
  • Germany5%
  • Canada4%
  • Belgium4%

The lab's institution and country are the corresponding author's.

Rival platforms, head to head

AVITI Element Biosciences 171
short-read
NovaSeq X Illumina 1,309

Latest preprints using AVITI

Who started using AVITI recently?

61 institutions posted their first preprint using AVITI since April 2025 in the last 6 months, including INRAE, VIB and Leipzig University.

  1. INRAEAug 17, 2026
  2. VIBOct 16, 2026
  3. Leipzig UniversityJun 2, 2026
  4. Emory UniversityJun 4, 2026
  5. California State University, NorthridgeJun 4, 2026
  6. Auburn UniversityJun 8, 2026
  7. Max Planck Institute for Terrestrial MicrobiologyJun 9, 2026
  8. Institute of Science TokyoJun 10, 2026
  9. Institute for Research in Immunology and CancerJun 15, 2026
  10. Murdoch Children’s Research InstituteJun 17, 2026

An institution counts as new when its first preprint using AVITI since April 2025 was posted in the last 6 months; the date is that first preprint.

What do labs use alongside AVITI?

Preprints using AVITI most often also use Chromium, NextSeq and NovaSeq X. The count is preprints using both.

What is AVITI used for?

Preprints using AVITI are most often in genomics, microbiology and molecular biology.

Fields

Genomics 73Microbiology 68Molecular biology 40Cancer biology 30Immunology 27Cell biology 26

Where the work was published

  1. Nature Communications6
  2. G3: Genes, Genomes, Genetics4
  3. Proceedings of the National Academy of Sciences4
  4. Cell3
  5. ISME Communications3
  6. Journal of the American Heart Association2
How we count which preprints use each platform

An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.

Want to reach out to the labs using AVITI?

Get the PIs behind the preprints: institutions, labs, and how to reach them.

Institutions with the most preprints using AVITI